AMN Healthcare (AMN) CFO corrects RSU holdings and updates equity awards
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
AMN Healthcare Services’ CFO/COO, Brian M. Scott, filed an amended Form 4 to update his equity holdings after January 15, 2026 transactions. The filing shows 8,843 Restricted Stock Units vested into common stock, with 3,592 shares withheld at $19.55 per share for taxes, leaving 13,093 common shares held directly.
After these transactions, he holds 17,956 Restricted Stock Units from a 2025 grant and 40,920 Restricted Stock Units from a new January 15, 2026 grant, each unit representing one share of AMN common stock. The amendment corrects a prior overstatement, clarifying that 40,920, not 81,840, derivative securities were beneficially owned following the reported transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
8,843 shares exercised/converted
Mixed
4 txns
Insider
Scott Brian M.
Role
CFO/COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 8,843 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 40,920 | $0.00 | -- |
| Exercise | Common Stock | 8,843 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,592 | $19.55 | $70K |
Holdings After Transaction:
Restricted Stock Units — 17,956 shares (Direct);
Common Stock — 16,685 shares (Direct)
Footnotes (1)
- Common stock acquired on the vesting of Restricted Stock Units. Number of shares withheld for tax purposes. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units set forth in this row were granted on January 15, 2025 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. Restricted Stock Units do not have an expiration date. The Restricted Stock Units reflected in this row were granted pursuant to the AMN Healthcare 2025 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. The Restricted Stock Units set forth in this row were granted on January 15, 2026 and vest in three tranches on each of the first, second, and third anniversaries of the grant date and the grantee's provision of three periods of credited service. Due to an administrative error, the Form 4 filed by the reporting person on January 16, 2026, overstated the amount of derivative securities beneficially owned following the reported transaction by 40,920 shares. This Form 4 is being amended and restated to reflect that, following the reported transaction, 40,920 securities were beneficially owned by reporting person, not 81,840 as previously reported.
FAQ
What insider activity did AMN (AMN) disclose for January 15, 2026?
AMN disclosed that its CFO/COO, Brian M. Scott, had 8,843 Restricted Stock Units vest into common stock on January 15, 2026. The filing also shows shares withheld for taxes and a new grant of 40,920 Restricted Stock Units on the same date.
What Restricted Stock Unit grants are reported in this AMN Form 4/A?
The filing reports two Restricted Stock Unit positions: 17,956 units from a grant under the AMN Healthcare 2017 Equity Plan and 40,920 units from a January 15, 2026 grant under the AMN Healthcare 2025 Equity Plan, each unit convertible into one share of common stock.
How do AMN’s Restricted Stock Units for the CFO/COO vest over time?
Both the January 15, 2025 and January 15, 2026 Restricted Stock Unit grants vest in three tranches. They vest on each of the first, second, and third anniversaries of the grant date, subject to the grantee providing three periods of credited service.
Why was this AMN Form 4 amended for the CFO/COO?
The amendment corrects an administrative error in the original January 16, 2026 filing. That filing overstated derivative securities beneficially owned after the transaction by 40,920 shares; the corrected amount is 40,920, not 81,840, derivative securities beneficially owned.